comparemela.com

Latest Breaking News On - Wynnefield capital inc - Page 4 : comparemela.com

Cutter & CO Brokerage Inc. Has $1.36 Million Stock Holdings in S&W Seed (NASDAQ:SANW)

Cutter & CO Brokerage Inc. Has $1.36 Million Stock Holdings in S&W Seed (NASDAQ:SANW)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Colorado
United-states
Longmont
Sw-seed-company
Nasdaq
Exchange-commission
Wynnefield-capital-inc
Cutter-co-brokerage-inc
Sw-seed-company-profile
Free-report
Wynnefield-capital

Cutter & CO Brokerage Inc. Trims Stake in S&W Seed (NASDAQ:SANW)

Cutter & CO Brokerage Inc. Trims Stake in S&W Seed (NASDAQ:SANW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Longmont
Colorado
United-states
Sw-seed-company
Wynnefield-capital-inc
Cutter-co-brokerage-inc
Free-report
Wynnefield-capital
Get-free-report
Visit-holdingschannel

Brokerages Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Price Target at $78.60

Brokerages Set Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Price Target at $78.60
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Cedric-francois
Pascal-deschatelets
Securities-exchange-commission
Profund-advisors
Apellis-pharmaceuticals-inc
News-ratings-for-apellis-pharmaceuticals-daily
Charles-schwab-investment-management-inc
Jefferies-financial-group
Needham-company
Wynnefield-capital-inc

Jennison Associates LLC Has $196.10 Million Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)

Jennison Associates LLC lessened its holdings in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 7.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,275,922 shares of the company’s stock after selling 266,287 shares during the period. Jennison Associates LLC owned 2.76% of Apellis Pharmaceuticals […]

United-states
American
Nur-nicholson
Pascal-deschatelets
Raymond-james
Wynnefield-capital-inc
Jefferies-financial-group
Goldman-sachs-group
Apellis-pharmaceuticals
Apellis-pharmaceuticals-stock-down
Quarter-for-apellis-pharmaceuticals
Jpmorgan-chase-co

Wedbush Weighs in on Apellis Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:APLS)

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush dropped their FY2025 EPS estimates for Apellis Pharmaceuticals in a report released on Wednesday, April 17th. Wedbush analyst L. Chico now expects that the company will earn $2.23 per share for the year, down from their prior estimate of $2.24. Wedbush currently has […]

United-states
American
Adamj-townsend
Robertw-baird
James-george-chopas
Securities-exchange-commission
Hedge-funds-weigh-in-on-apellis-pharmaceuticals
Apellis-pharmaceuticals-inc
Apellis-pharmaceuticals-stock-performance
Charles-schwab-investment-management-inc
News-ratings-for-apellis-pharmaceuticals-daily
Goldman-sachs-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.